ULTRAGENYX PHARMACEUTICAL INC. (RARE) Gross profit 2017–2018
ULTRAGENYX PHARMACEUTICAL INC. (RARE) annual gross profit history from SEC filings — each fiscal year as reported.
$50.3MFY2018 · since FY2017: $2.6M → $50.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2018 | $50.3M | +1828.3% |
| FY2017 | $2.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RARE financial trends
RARE RevenueRARE Net incomeRARE Net marginRARE Gross marginRARE Operating incomeRARE Operating marginRARE Operating cash flowRARE Free cash flowRARE Capital expendituresRARE Return on equityRARE Stock buybacksRARE Dividends paidRARE Total assetsRARE Total liabilitiesRARE Shareholders’ equityRARE overview →